Firethorn Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Buy	10,207 +89	+0.9%	+$12K	0.52%	45
2026 Q1	$1.29M	Sell	10,118 -49	-0.5%	-$6.12K	0.47%	52
2025 Q4	$1.24M	Buy	10,167 +62	+0.6%	+$7.11K	0.46%	48
2025 Q3	$1.01M	Sell	10,105 -108	-1%	-$9.73K	0.4%	61
2025 Q2	$847K	Buy	10,213 +615	+6%	+$49.1K	0.37%	61
2025 Q1	$778K	Buy	9,598 +751	+8%	+$67.1K	0.37%	57
2024 Q4	$797K	Buy	8,847 +769	+10%	+$74.5K	0.4%	54
2024 Q3	$798K	Buy	8,078 +329	+4%	+$32.3K	0.41%	53
2024 Q2	$718K	Buy	7,749 +1,016	+15%	+$91.1K	0.41%	55
2024 Q1	$639K	Sell	6,733 -369	-5%	-$34.2K	0.38%	58
2023 Q4	$634K	Buy	7,102 +1,391	+24%	+$103K	0.42%	50
2023 Q3	$417K	Buy	5,711 +829	+17%	+$66.2K	0.32%	66
2023 Q2	$406K	Buy	4,882 +318	+7%	+$26.6K	0.3%	64
2023 Q1	$375K	Buy	4,564 +337	+8%	+$28K	0.29%	66
2022 Q4	$351K	Buy	4,227 +612	+17%	+$49.5K	0.3%	76
2022 Q3	$287K	Buy	3,615 +135	+4%	+$11.4K	0.27%	85
2022 Q2	$277K	Buy	3,480 +446	+15%	+$33.5K	0.22%	93
2022 Q1	$273K	Buy	+3,034	New	+$280K	0.21%	98